| pubmed-article:16889456 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16889456 | lifeskim:mentions | umls-concept:C0035648 | lld:lifeskim |
| pubmed-article:16889456 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:16889456 | lifeskim:mentions | umls-concept:C0036341 | lld:lifeskim |
| pubmed-article:16889456 | lifeskim:mentions | umls-concept:C0033522 | lld:lifeskim |
| pubmed-article:16889456 | lifeskim:mentions | umls-concept:C1548819 | lld:lifeskim |
| pubmed-article:16889456 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:16889456 | pubmed:dateCreated | 2006-8-7 | lld:pubmed |
| pubmed-article:16889456 | pubmed:abstractText | This study aimed to prospectively identify the best single predictor and the best set of predictors of risk for nonadherence with anti-psychotic medication in the treatment of patients with schizophrenia. | lld:pubmed |
| pubmed-article:16889456 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16889456 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16889456 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16889456 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16889456 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16889456 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16889456 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:16889456 | pubmed:issn | 0160-6689 | lld:pubmed |
| pubmed-article:16889456 | pubmed:author | pubmed-author:DolderChristi... | lld:pubmed |
| pubmed-article:16889456 | pubmed:author | pubmed-author:LacroJonathan... | lld:pubmed |
| pubmed-article:16889456 | pubmed:author | pubmed-author:Ascher-Svanum... | lld:pubmed |
| pubmed-article:16889456 | pubmed:author | pubmed-author:ZhuBaojinB | lld:pubmed |
| pubmed-article:16889456 | pubmed:author | pubmed-author:FariesDouglas... | lld:pubmed |
| pubmed-article:16889456 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16889456 | pubmed:volume | 67 | lld:pubmed |
| pubmed-article:16889456 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16889456 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16889456 | pubmed:pagination | 1114-23 | lld:pubmed |
| pubmed-article:16889456 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:16889456 | pubmed:meshHeading | pubmed-meshheading:16889456... | lld:pubmed |
| pubmed-article:16889456 | pubmed:meshHeading | pubmed-meshheading:16889456... | lld:pubmed |
| pubmed-article:16889456 | pubmed:meshHeading | pubmed-meshheading:16889456... | lld:pubmed |
| pubmed-article:16889456 | pubmed:meshHeading | pubmed-meshheading:16889456... | lld:pubmed |
| pubmed-article:16889456 | pubmed:meshHeading | pubmed-meshheading:16889456... | lld:pubmed |
| pubmed-article:16889456 | pubmed:meshHeading | pubmed-meshheading:16889456... | lld:pubmed |
| pubmed-article:16889456 | pubmed:meshHeading | pubmed-meshheading:16889456... | lld:pubmed |
| pubmed-article:16889456 | pubmed:meshHeading | pubmed-meshheading:16889456... | lld:pubmed |
| pubmed-article:16889456 | pubmed:meshHeading | pubmed-meshheading:16889456... | lld:pubmed |
| pubmed-article:16889456 | pubmed:meshHeading | pubmed-meshheading:16889456... | lld:pubmed |
| pubmed-article:16889456 | pubmed:meshHeading | pubmed-meshheading:16889456... | lld:pubmed |
| pubmed-article:16889456 | pubmed:meshHeading | pubmed-meshheading:16889456... | lld:pubmed |
| pubmed-article:16889456 | pubmed:meshHeading | pubmed-meshheading:16889456... | lld:pubmed |
| pubmed-article:16889456 | pubmed:meshHeading | pubmed-meshheading:16889456... | lld:pubmed |
| pubmed-article:16889456 | pubmed:meshHeading | pubmed-meshheading:16889456... | lld:pubmed |
| pubmed-article:16889456 | pubmed:meshHeading | pubmed-meshheading:16889456... | lld:pubmed |
| pubmed-article:16889456 | pubmed:meshHeading | pubmed-meshheading:16889456... | lld:pubmed |
| pubmed-article:16889456 | pubmed:meshHeading | pubmed-meshheading:16889456... | lld:pubmed |
| pubmed-article:16889456 | pubmed:meshHeading | pubmed-meshheading:16889456... | lld:pubmed |
| pubmed-article:16889456 | pubmed:meshHeading | pubmed-meshheading:16889456... | lld:pubmed |
| pubmed-article:16889456 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16889456 | pubmed:articleTitle | A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia. | lld:pubmed |
| pubmed-article:16889456 | pubmed:affiliation | Eli Lilly and Co., Lilly Corporate Center, Indianapolis, IN 46285, USA. haya@lilly.com | lld:pubmed |
| pubmed-article:16889456 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16889456 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:16889456 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:16889456 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:16889456 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16889456 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16889456 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16889456 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16889456 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16889456 | lld:pubmed |
